NAPROXEN
- Product NDC
- 68071-4995
- 11-digit product format
- 680714995
- Labeler code
- 68071
- Product ID
- 68071-4995_bbb3120e-d434-51e7-e053-2995a90a3194
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2016-07-06
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4995-2 | 68071499502 | 20 TABLET in 1 BOTTLE (68071-4995-2) | 20 tablet | 2019-07-26 | 0000-00-00 | No | No | Current |